New York, Abuja, Boston: Representatives of the Nigerian government and Aurora Technology and Healthcare Global Holding Corp. (Aurora) are jointly announcing the signing of a landmark collaboration memorandum to address the issue of rising breast cancer incidence in Nigeria. This is the first Aurora entry into the vast African continent.

This landmark Strategic Agreement was signed on September 24th, 2021 and was evidenced by the Nigeria Consul General, the Honorable Nicholas Ella, Esq. at the Nigerian Consulate in New York City. The signees were Olivia Ho Cheng, Dr. Julie Loh and Frank Liu of Aurora, Dr. Ugoji Eze, Esq. a prominent UN activist and Mr. Festus Uzoma Mbisiogu, a renowned Nigerian philanthropist and CEO of Shanghai Engineering Works Limited and Chairman of Blue Diamond Group.

Aurora CEO, Ms. Olivia Ho Cheng, stated “Aurora from its inception made the solemn commitment to take on the profound and arduous global challenge of breast cancer. The Africa continent, with 1.26 billion in population, should not and cannot be ignored in this respect. Our team is absolutely elated that such an opportunity was presented to us so that we could enter into this vast and thus far untouched continent in the state-of-the-art breast healthcare!”

Breast cancer surpassed lung cancer in 2020 as the most frequently diagnosed cancer in the world with 2.3 million newly diagnosed cases and more than 650,000 deaths annually. In Nigeria, breast cancer is becoming……

The parties at the signing ceremony have agreed to co-develop Breast Cancer Centers of Excellence which will deliver comprehensive, compassionate breast cancer care combined with advanced basic and translational cancer research. Ultimately, the collected partners seek to improve the prognosis of breast cancer patients and enhance women’s health and wellbeing.

For the parties in the tripartite agreement, the introduction of Aurora’s breast-dedicated MRI technology holds great promise to decrease the burden of breast cancer on the women of Nigeria where high-quality breast cancer screening, diagnosis and treatment is not widely available. The goal of this collaboration will be to build a new platform for breast cancer research, education, clinical application, commercialization and business operations in Nigeria and eventually other countries in Africa.

With emotional excitement, the CEO of Shanghai Engineering Works Limited and Chairman of Blue Diamond Group, Mr. Mbisiogu and Ms. Eze expressed delight that “this system, when introduced in Nigeria, will alleviate the plight of our women and girls by improving the very early detection and treatment of breast cancer.”

Aurora Technology and Healthcare Global Holding (“Aurora Group”) was formed in early 1990 by a team of elite scientists, clinicians and engineers from MIT and Harvard.  By 2000, Aurora had developed and successfully marketed a dedicated Breast Magnetic Resonance Imaging (BMRI) system that consistently outperforms mammography and even breast imaging performed on “whole-body” MRI machines.

Aurora has successfully commercialized the Aurora system in the US, Europe and Asia as a superior diagnostic modality for breast cancer patients.  In recent years, Aurora continues to expand the clinical application of the Aurora system in breast cancer screening throughout the world, while continuing to engage in state-of-the-art research and development in-house and through strategic alliances with top universities in north America and Asia. This is the first engagement for Aurora in Nigeria.

Contact:  

Abraham Morse, MD, MBA

Medical Director

Aurora Healthcare US Corp

anmorse@auroramri.com